Avet-logo (Avet Logo)
Amphotericin B Injectable, Liposomal
Product Images NDC 23155-594
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amphotericin B (NDC 23155-594). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Carton-label (Carton Label)
Packaging label for Amphotericin B liposomal injection, 50 mg/vial, by Avet Pharma. The label indicates the product is for intravenous infusion only and must be reconstituted and further diluted. It includes manufacturer details, dosage form as single-dose vial, and storage instructions. The label also contains drug warnings in red text and a barcode.*
Figure1 (Figure1)
A line graph depicting the mean change in creatinine levels (mg/dL) over time in weeks for two Amphotericin B treatments from Study 94-0-002. The x-axis represents weeks on study (0 to 5), and the y-axis shows mean change in creatinine levels (0 to 0.7 mg/dL). Two lines compare Amphotericin B Liposomal Injection 3 mg/kg/day versus Amphotericin B 0.6 mg/kg/day, with sample sizes annotated at each time point.*
Figure2 (Figure2)
A line graph titled 'Mean Creatinine Concentrations Over Time' depicting mean creatinine concentration (mg/dL) on the y-axis and day of test on the x-axis. Two sets of data: one for patients whose pretreatment values were greater than 1.7 mg/dL, shown with diamond markers decreasing from about 3.2 to 2.0 over 40 days; another for all episodes, shown with square markers fluctuating near 1.5 to 1.0. Numeric annotations appear near data points.*
Liposome (Liposome)
A grayscale cross-section illustration of a liposome showing its structural components. The phospholipid bilayer forms the outer and inner membranes, with amphotericin B molecules embedded inside. Labels point to the phospholipid bilayer and amphotericin B molecules within the liposome.*
Structure (Structure)
Chemical structure diagram of Amphotericin B showing its molecular framework with multiple hydroxyl groups, double bonds, and ring structures. The structure depicts the arrangement of atoms and bonds characteristic of Amphotericin B, an intravenous liposomal injectable drug.*
Vial-label (Vial Label)
Label for Amphotericin B Liposome for Injection 50 mg/vial, a sterile, nonpyrogenic injectable liposomal formulation for intravenous use. The single-dose vial label includes storage instructions, manufacturer details (Emcure Pharmaceuticals Ltd., India), and the labeler (Avet Pharmaceuticals Inc.). It notes that the product is preservative-free and must be reconstituted and diluted prior to infusion.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
